We are live on ! Find out more
PA

Profund Advisors Portfolio holdings

AUM $2.72B
1-Year Est. Return 47.27%
This Fund
S&P 500
This Quarter Est. Return
+14.4%
1 Year Est. Return
+47.27%
3 Year Est. Return
+155.16%
5 Year Est. Return
+217.35%
10 Year Est. Return
+1,111.88%
AUM
$1.62B
AUM Growth
+$77.5M
Cap. Flow
-$61.1M
Cap. Flow %
-3.78%
Top 10 Hldgs %
28.88%
Holding
1,192
New
187
Increased
321
Reduced
580
Closed
103

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$3.14M
2
AVGO icon
Broadcom
AVGO
+$3.01M
3
TSLA icon
Tesla
TSLA
+$2.23M
4
TWST icon
Twist Bioscience
TWST
+$1.76M
5
NVAX icon
Novavax
NVAX
+$1.74M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$26.2M
2
DHR icon
Danaher
DHR
+$17.1M
3
AMGN icon
Amgen
AMGN
+$12.4M
4
GILD icon
Gilead Sciences
GILD
+$9.52M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$7.11M

Sector Composition

Rank Sector Weight
1 Technology 33.28%
2 Healthcare 16.86%
3 Consumer Discretionary 11.45%
4 Communication Services 8.63%
5 Energy 7.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INSM icon
251
Insmed
INSM
$28.6B
$1.22M 0.08%
+71,395
New +$1.39M
BHP icon
252
BHP
BHP
$230B
$1.22M 0.08%
19,188
-2,210
-10% -$142K
BEAM icon
253
Beam Therapeutics
BEAM
$2.84B
$1.22M 0.08%
39,707
+31,589
+389% +$1.25M
PINS icon
254
Pinterest
PINS
$13.4B
$1.21M 0.07%
44,382
-6,726
-13% -$174K
VCYT icon
255
Veracyte
VCYT
$3.8B
$1.21M 0.07%
+54,244
New +$1.31M
JNPR
256
DELISTED
Juniper Networks
JNPR
$1.2M 0.07%
34,816
-4,268
-11% -$135K
TWST icon
257
Twist Bioscience
TWST
$7.25B
$1.2M 0.07%
+79,459
New +$1.76M
PCG icon
258
PG&E
PCG
$38.5B
$1.2M 0.07%
73,927
-849
-1% -$13.4K
BLK icon
259
Blackrock
BLK
$176B
$1.19M 0.07%
1,776
-61
-3% -$43K
LMT icon
260
Lockheed Martin
LMT
$136B
$1.19M 0.07%
2,507
+165
+7% +$77.4K
GFI icon
261
Gold Fields
GFI
$36.5B
$1.18M 0.07%
88,910
+8,217
+10% +$91.6K
SRPT icon
262
Sarepta Therapeutics
SRPT
$1.77B
$1.18M 0.07%
8,592
-1,200
-12% -$156K
ACAD icon
263
Acadia Pharmaceuticals
ACAD
$5.03B
$1.18M 0.07%
+62,741
New +$1.19M
MRTX
264
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$1.17M 0.07%
31,527
+25,747
+445% +$1.16M
AKRO
265
DELISTED
Akero Therapeutics
AKRO
$1.17M 0.07%
+30,578
New +$1.36M
CI icon
266
Cigna
CI
$74.6B
$1.17M 0.07%
4,569
-466
-9% -$136K
TRGP icon
267
Targa Resources
TRGP
$55.1B
$1.16M 0.07%
15,957
+2,009
+14% +$148K
BILI icon
268
Bilibili
BILI
$7.84B
$1.15M 0.07%
48,896
-1,851
-4% -$44K
KYMR icon
269
Kymera Therapeutics
KYMR
$8.94B
$1.15M 0.07%
+38,738
New +$1.25M
CTVA icon
270
Corteva
CTVA
$51.3B
$1.15M 0.07%
19,011
-1,021
-5% -$62.4K
CIEN icon
271
Ciena
CIEN
$58.4B
$1.14M 0.07%
21,746
-4,741
-18% -$237K
MTCH icon
272
Match Group
MTCH
$8.55B
$1.13M 0.07%
29,406
+1,766
+6% +$77K
MPWR icon
273
Monolithic Power Systems
MPWR
$68.9B
$1.13M 0.07%
2,251
+564
+33% +$259K
DNLI icon
274
Denali Therapeutics
DNLI
$3.97B
$1.12M 0.07%
48,827
+33,960
+228% +$935K
GE icon
275
GE Aerospace
GE
$384B
$1.11M 0.07%
14,579
-4,924
-25% -$329K
9 10
11
12 13

Similar funds

XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
TAM
Timucuan Asset Management Jacksonville, Florida $2.72B AUM 4.95% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
GC
Giverny Capital Montreal, Quebec, Canada $2.73B AUM 14.09% 1-Year Est. Return
LMIM
Lockheed Martin Investment Management Bethesda, Maryland $2.73B AUM 28.24% 1-Year Est. Return
PCM
Patient Capital Management Baltimore, Maryland $2.74B AUM 43.59% 1-Year Est. Return
CIAS
CBIZ Investment Advisory Services Independence, Ohio $2.74B AUM 14.19% 1-Year Est. Return
NB
Nicolet Bankshares Green Bay, Wisconsin $2.71B AUM 17.55% 1-Year Est. Return

Profund Advisors's Q1 2023 Portfolio in Review

As of Q1 2023, Profund Advisors held 1,192 positions worth $1.62B, up 5% from $1.54B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Profund Advisors withdrew a net $61.1M in Q1 2023, closing 103 positions and reducing 580 holdings. Its most notable exit was Cheniere Energy, an estimated $2.09M position sold in full.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Profund Advisors opened a new position in Twist Bioscience worth $1.2M.

  • Profund Advisors's largest Q1 2023 buy was Twist Bioscience: 79,459 shares worth $1.2M.
  • Profund Advisors added most to NVIDIA in Q1 2023, an estimated $3.14M increase.
  • Profund Advisors's biggest Q1 2023 reduction was AbbVie, cutting an estimated $26.2M.
  • Profund Advisors fully exited Cheniere Energy in Q1 2023, selling an estimated $2.09M.
  • Profund Advisors's ten largest holdings make up 29% of its $1.62B portfolio in Q1 2023.
  • Profund Advisors opened 187 new positions and closed 103 in Q1 2023.
  • Profund Advisors's portfolio value rose 5% quarter-over-quarter to $1.62B.

Based on Profund Advisors's 13F filing for Q1 2023, filed 12 May 2023.